financetom
Business
financetom
/
Business
/
PulteGroup Q3 Beats Estimates: Home Closings Up 12%, CEO Highlights Fed's Role in Addressing Affordability
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PulteGroup Q3 Beats Estimates: Home Closings Up 12%, CEO Highlights Fed's Role in Addressing Affordability
Oct 22, 2024 12:30 PM

PulteGroup, Inc. ( PHM ) shares are trading lower after the company reported third-quarter results.

Revenue stood at $4.48 billion, beating the consensus of $4.26 billion.

Reported home sale revenues rose 12% to $4.3 billion, with higher revenues reflecting a 12% increase in closings to 7,924 homes and an average sales price of $548,000 (flat Y/Y).

The gross margin for home sales stood at 28.8%, vs. 29.5% a year ago.

Net new orders fell to 7,031 from 7,065 homes last year. However, the dollar value of net new orders rose 3% to $3.9 billion in the third quarter.

GAAP EPS of $3.35 beat the consensus of $3.15.

At the end of the third quarter, the company’s backlog was 12,089  homes, valued at $7.7 billion.

The company ended the year with $1.5 billion of cash and a debt-to-capital ratio of 12.3%.

During the quarter, the company repurchased 2.5 million of its common shares for $320 million, or an average price of $126.05 per share.

Ryan Marshall, PulteGroup ( PHM ) President and CEO, said, “Years of underbuilding has created a structural shortage of homes and correspondingly high home prices, so the Federal Reserve’s pivot to lowering interest rates provides a powerful tool in helping to address the affordability challenge faced by today’s homebuyers.”

“Given our strong third quarter and nine-month financial results, we are well positioned to deliver a record year of earnings for the Company,” added Marshall.

Investors can gain exposure to the stock via IShares U.S. Home Construction ETF ( ITB ) and SMI 3Fourteen Full-Cycle Trend ETF ( FCTE ) .

Price Action: PHM shares are down 5.8% at $135.90 at the last check Tuesday.

Image via Shutterstock

Read Next:

Hurricane Milton To Deliver $2.5B Blow To Florida’s Homebuilding Sector, Goldman Sachs Says

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved